Aspire Biopharma Holdings Financials - Benzinga

Aspire Biopharma Holdings Inc

ASBPNASDAQ

Trade with Public

Trade with Public

$8.41

0.141.69%

마지막 업데이트: Aug 26, 1:06 PM

개요 뉴스 실적 전망 이벤트재무심리 지분 현황 비교 주식 보고서

Aspire Biopharma Holdings Financials

Aspire Biopharma Holdings (ASBP) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Aspire Biopharma Hldgs Q1 EPS $(20.57) Up From $(504.88) YoY, Sales $28.353K

Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(20.57) per share. This is a 95.93 percent increase over losses of $(504.88) per share from the same period last year. The company reported $28.353

Benzinga Newsdesk

PRO
Aspire Biopharma Hldgs Q4 EPS $(1.84) Down From $(1.10) YoY, Sales $4.261K Up From $0 YoY

Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(1.84) per share. This is a 67.27 percent decrease over losses of $(1.10) per share from the same period last year. The company reported $4.261 thousand

Benzinga Newsdesk

PRO
Aspire Biopharma Hldgs Q3 EPS $(0.04) Down From $(0.01) YoY, Sales $1.941K

Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(0.04) per share. This is a 300 percent decrease over losses of $(0.01) per share from the same period last year. The company reported $1.941 thousand

Benzinga Newsdesk

Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 0.2% on Thursday. The Dow traded up 0.20% to 46,532.02 while the NASDAQ rose 0.34% to 22,833.17. The S&P 500 also rose, gaining, 0.07% to 6,715.87.

Avi Kapoor

Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August

Avi Kapoor

PRO
Aspire Biopharma Hldgs Q2 EPS $(0.04)

Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(0.04) per share.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved